The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2025
Filed:
Jul. 06, 2022
Applicant:
Lanova Medicines Development Co., Ltd., Shanghai, CN;
Inventors:
Runsheng Li, Shanghai, CN;
Wentao Huang, Shanghai, CN;
Assignee:
LaNova Medicines Development Co., Ltd., Shanghai, CN;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2005.12); A61P 35/00 (2005.12); C07K 16/28 (2005.12); A61K 39/00 (2005.12);
U.S. Cl.
CPC ...
C07K 16/2809 (2012.12); A61P 35/00 (2017.12); A61K 2039/505 (2012.12); C07K 2317/21 (2012.12); C07K 2317/31 (2012.12); C07K 2317/33 (2012.12); C07K 2317/565 (2012.12); C07K 2317/732 (2012.12); C07K 2317/734 (2012.12); C07K 2317/76 (2012.12); C07K 2317/92 (2012.12); C07K 2317/94 (2012.12);
Abstract
Provided are chimeric antigen receptors that include an antibody or fragment thereof having binding specificity to the human GPRC5D protein. The chimeric antigen receptors and immune cells expressing the chimeric antigen receptors are capable of targeting cancer cells expressing GPRC5D, and thus can be used to treat the cancer, in particular hematological cancer.
Li, Runsheng. (2025). Chimeric antigen receptors targeting gprc5d (U.S. Patent No. 12281162). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12281162
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile